2-21037212-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000384.3(APOB):​c.581C>T​(p.Thr194Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,614,104 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. T194T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0023 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 39 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.725
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025214553).
BP6
Variant 2-21037212-G-A is Benign according to our data. Variant chr2-21037212-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 334181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-21037212-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.051 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
APOBNM_000384.3 linkuse as main transcriptc.581C>T p.Thr194Met missense_variant 6/29 ENST00000233242.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
APOBENST00000233242.5 linkuse as main transcriptc.581C>T p.Thr194Met missense_variant 6/291 NM_000384.3 P1
APOBENST00000399256.4 linkuse as main transcriptc.581C>T p.Thr194Met missense_variant 6/171
APOBENST00000673739.2 linkuse as main transcriptc.427C>T p.Arg143Ter stop_gained, NMD_transcript_variant 5/25
APOBENST00000673882.2 linkuse as main transcriptc.427C>T p.Arg143Ter stop_gained, NMD_transcript_variant 5/23

Frequencies

GnomAD3 genomes
AF:
0.00230
AC:
350
AN:
152128
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0565
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00486
AC:
1221
AN:
251406
Hom.:
26
AF XY:
0.00439
AC XY:
596
AN XY:
135872
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00333
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0551
Gnomad SAS exome
AF:
0.00173
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00152
AC:
2229
AN:
1461858
Hom.:
39
Cov.:
32
AF XY:
0.00149
AC XY:
1083
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.000358
Gnomad4 AMR exome
AF:
0.00288
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0407
Gnomad4 SAS exome
AF:
0.00169
Gnomad4 FIN exome
AF:
0.0000374
Gnomad4 NFE exome
AF:
0.000128
Gnomad4 OTH exome
AF:
0.00296
GnomAD4 genome
AF:
0.00228
AC:
347
AN:
152246
Hom.:
9
Cov.:
32
AF XY:
0.00261
AC XY:
194
AN XY:
74426
show subpopulations
Gnomad4 AFR
AF:
0.000193
Gnomad4 AMR
AF:
0.00144
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0563
Gnomad4 SAS
AF:
0.00249
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00214
Hom.:
9
Bravo
AF:
0.00267
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00468
AC:
568
Asia WGS
AF:
0.0240
AC:
84
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoMay 27, 2022- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 18, 2019This variant is associated with the following publications: (PMID: 33303402) -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesApr 11, 2022- -
Familial hypercholesterolemia Benign:2
Benign, criteria provided, single submitterclinical testingGENinCode PLCJun 23, 2022- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJun 22, 2017- -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hypercholesterolemia, familial, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingRobarts Research Institute, Western UniversityJan 02, 2018- -
Familial hypobetalipoproteinemia 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 07, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.054
.;T
Eigen
Benign
-0.023
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.33
N
LIST_S2
Uncertain
0.87
.;D
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-2.5
N;D
REVEL
Benign
0.11
Sift
Uncertain
0.0060
D;D
Sift4G
Uncertain
0.0020
D;D
Vest4
0.22
MVP
0.68
MPC
0.23
ClinPred
0.023
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13306198; hg19: chr2-21260084; API